KR900005993A - 레트로바이러스에 의해 유발되는 질병 치료용 약제 - Google Patents

레트로바이러스에 의해 유발되는 질병 치료용 약제 Download PDF

Info

Publication number
KR900005993A
KR900005993A KR1019890014214A KR890014214A KR900005993A KR 900005993 A KR900005993 A KR 900005993A KR 1019890014214 A KR1019890014214 A KR 1019890014214A KR 890014214 A KR890014214 A KR 890014214A KR 900005993 A KR900005993 A KR 900005993A
Authority
KR
South Korea
Prior art keywords
amino acid
treatment
acid derivative
retroviruses
het
Prior art date
Application number
KR1019890014214A
Other languages
English (en)
Inventor
라다쓰 피터
슈미트게스 클라우스제이
이.폰데어헬름 클라우스
Original Assignee
위르겐 호이만, 라인 하르트 쉬틀러
메르크 파텐트 게젤샤프트 미트 베슈렝크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 위르겐 호이만, 라인 하르트 쉬틀러, 메르크 파텐트 게젤샤프트 미트 베슈렝크터 하프퉁 filed Critical 위르겐 호이만, 라인 하르트 쉬틀러
Publication of KR900005993A publication Critical patent/KR900005993A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/315—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by selective application of heat to a heat sensitive printing or impression-transfer material
    • B41J2/32—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by selective application of heat to a heat sensitive printing or impression-transfer material using thermal heads
    • B41J2/35—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by selective application of heat to a heat sensitive printing or impression-transfer material using thermal heads providing current or voltage to the thermal head
    • B41J2/355—Control circuits for heating-element selection
    • B41J2/36—Print density control
    • B41J2/365—Print density control by compensation for variation in temperature
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/315—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by selective application of heat to a heat sensitive printing or impression-transfer material
    • B41J2/38—Preheating, i.e. heating to a temperature insufficient to cause printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electronic Switches (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

레트로바이러스에 의해 유발되는 질병 치료용 약제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 레트로바이러스에 의해 유발되는 질병을 치료하는 약제를 제조하기 위한, 테트로바이러스 프로테아제의 활성을 저해하고 다음 일반식(Ⅰ)의 구조성분을 함유하는 아미노산 유도체 또는 이의 생리학적으로 허용되는 염의 용도.
    -NR1-CHR2-CR3-(CHR4)n-CO-
    상기식에서, R1, R4, R5및 R6는 각기 H 또는 알킬이고, R2는 H, 알킬 또는 각 경우 치환 또는 비치환된 아릴, 아릴알킬, 시클로알킬, 시클로알킬알킬, Het 또는 Het-알킬이고, R3는 (H,OH), (H,NR5R6) 또는 O이고, Het는 5- 또는 6-원 N-, S- 또는 O- 함유 포화 또는 불포화 헤테로시클릭 래디칼이고, n은 1 또는 2이다.
  2. 레트로바이러스에 의해 유발되는 질병을 퇴치하는데 있어서, 레트로바이러스 프로테아제의 활성을 저해하고 일반식(Ⅰ)의 구조성분을 함유하는 아미노산 유도체 또는 이의 생리학적으로 허용되는 염의 용도.
  3. AIDS 치료용 약제를 제조하기 위한 제1항에 따른 아미노산 유도체의 용도.
  4. AIDS 퇴치에의 제2항에 따른 아미노산 유도체의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890014214A 1988-09-30 1989-10-04 레트로바이러스에 의해 유발되는 질병 치료용 약제 KR900005993A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3833746A DE3833746A1 (de) 1988-09-30 1988-09-30 Thermodruckverfahren mit vorheizung
DEP3833746.9 1988-10-05

Publications (1)

Publication Number Publication Date
KR900005993A true KR900005993A (ko) 1990-05-07

Family

ID=6364364

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014214A KR900005993A (ko) 1988-09-30 1989-10-04 레트로바이러스에 의해 유발되는 질병 치료용 약제

Country Status (2)

Country Link
KR (1) KR900005993A (ko)
DE (1) DE3833746A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665954B2 (en) * 1991-07-02 1996-01-25 Orbital Engine Company (Australia) Proprietary Limited Multicylinder two stroke cycle engine
EP0530748A3 (en) * 1991-09-03 1993-03-24 Eastman Kodak Company Printer head modulation technique for thermal printers
DE4133207A1 (de) * 1991-10-07 1993-04-15 Francotyp Postalia Gmbh Verfahren zum steuern der speisung eines thermodruck-heizelements
EP0568162A1 (de) * 1992-04-29 1993-11-03 Francotyp-Postalia GmbH Anordnung für eine ETR-Druckkopfansteuerung
DE4221275C2 (de) * 1992-06-26 1994-04-21 Francotyp Postalia Gmbh Ansteuerschaltung für eine elektrothermische Druckvorrichtung mit Widerstandsband
JP3311852B2 (ja) * 1994-02-17 2002-08-05 セイコープレシジョン株式会社 サーマルプリンタの駆動方法
JP2715917B2 (ja) * 1994-07-15 1998-02-18 村田機械株式会社 印字装置
DE4445053C2 (de) 1994-12-07 2003-04-10 Francotyp Postalia Ag Frankiermaschineninterne Schnittstellenschaltung
DE29504576U1 (de) * 1995-03-07 1995-05-11 Francotyp Postalia Gmbh Druckkopfthermosteuerung
DE10012360C2 (de) * 2000-03-14 2002-01-31 Skidata Ag Verfahren zur Steuerung der Heizelemente eines Thermodruckkopfes
DE102004027517B4 (de) * 2004-06-03 2007-05-10 Francotyp-Postalia Gmbh Anordnung und Verfahren zur Ansteuerung eines Thermotransferdruckkopfes
DE102005007220B4 (de) * 2005-02-15 2007-08-16 Francotyp-Postalia Gmbh Verfahren und Anordnung zum Steuern des Druckens eines Thermotransferdruckgeräts
DE102006009334A1 (de) 2006-03-01 2007-09-20 Francotyp-Postalia Gmbh Verfahren zur Qualitätsverbesserung des Druckens mit einem Thermotransferdruckkopf und Anordnung zur Durchführung des Verfahrens
JP7065644B2 (ja) * 2018-03-02 2022-05-12 東芝テック株式会社 サーマルプリンタ、サーマルプリンタの制御方法

Also Published As

Publication number Publication date
DE3833746A1 (de) 1990-04-05

Similar Documents

Publication Publication Date Title
KR900005993A (ko) 레트로바이러스에 의해 유발되는 질병 치료용 약제
DK275488A (da) Indolonderivater
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
TR199800720T2 (xx) Farnesil transferaz inhibe eden 2-kinolon t�revleri.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
ATE89547T1 (de) Dopamin-vorlaeufer.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
DK707988D0 (da) Fremgangsmaade til at haemme virus
KR880001596A (ko) 디하이드로피리딘 화합물-함유 뇌기능이상 치료제
GB1465025A (en) Substituted phenylisothioureas a process for their preparation and their use as medicaments
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
KR890012973A (ko) 이미다졸 유도체
GB1366644A (en) Sulphonyl benzimidazoles
KR890001540A (ko) 심부전증 치료제
SE8001981L (sv) Kompositioner for behandling av glaukom
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
KR880009017A (ko) 항바이러스 활성을 갖는 이속사졸 유도체 및 이를 함유하는 약제
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid